Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X G Dou

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|March 13, 2020
[Commentary: evidence, evidence, always evidence. 2019 Chinese practice guidelines for the prevention and treatment of hepatitis B virus mother-to-child transmission]Y Ding, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 28, 2022
[Why not both patient's age and family history should be necessary as the criteria for initiating treatment of patients with chronic HBV infection?]C Zhang, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 24, 2021
[Special liver disease in adult: rare, complicated, and new understanding]C Zhang, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 13, 2021
[Oral nucleos(t)ide analogues antiviral therapy reduces HBV-related HCC: consensus and contention]C Han, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 6, 2021
[Optimal timing significance and clinical implications for the treatment of chronic HBV-infected patients with normal ALT]Y X Fan, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 3, 2023
[Antiviral therapy for chronic hepatitis B: the imperative to move from scaling-up treatment to full treatment]Q J Sheng, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 2, 2026
[Progress in clinical research related to viral hepatitis in 2025]Y Ding, Y Li, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 24, 2021
[Early-stage clinical features, diagnosis and treatment progress of pregnancy-related liver disease]Y Ding, Q J Sheng, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 17, 2020
[Timing and selection of antiviral therapy with nucleos(t)ide analogues for prevention of hepatitis B virus-related HCC]C Han, P P Lai, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|March 2, 2019
[Considerations of using oral nucleos(t)ide analogues to interrupt mother-to-child transmission in HBV carrier pregnant woman with high viral load]Y Ding, Q J Sheng, X G Dou
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|March 13, 2020
[Commentary: evidence, evidence, always evidence. 2019 Chinese practice guidelines for the prevention and treatment of hepatitis B virus mother-to-child transmission]Y Ding, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 28, 2022
[Why not both patient's age and family history should be necessary as the criteria for initiating treatment of patients with chronic HBV infection?]C Zhang, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 24, 2021
[Special liver disease in adult: rare, complicated, and new understanding]C Zhang, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 13, 2021
[Oral nucleos(t)ide analogues antiviral therapy reduces HBV-related HCC: consensus and contention]C Han, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 6, 2021
[Optimal timing significance and clinical implications for the treatment of chronic HBV-infected patients with normal ALT]Y X Fan, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 3, 2023
[Antiviral therapy for chronic hepatitis B: the imperative to move from scaling-up treatment to full treatment]Q J Sheng, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 2, 2026
[Progress in clinical research related to viral hepatitis in 2025]Y Ding, Y Li, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 24, 2021
[Early-stage clinical features, diagnosis and treatment progress of pregnancy-related liver disease]Y Ding, Q J Sheng, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 17, 2020
[Timing and selection of antiviral therapy with nucleos(t)ide analogues for prevention of hepatitis B virus-related HCC]C Han, P P Lai, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|March 2, 2019
[Considerations of using oral nucleos(t)ide analogues to interrupt mother-to-child transmission in HBV carrier pregnant woman with high viral load]Y Ding, Q J Sheng, X G Dou
Pageof 4